	US 11,754,551 B2
	Reprogramming cell aging
Lorenz Studer, New York, NY (US); and Daniela Cornacchia, New York, NY (US)
Assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER, New York, NY (US)
Filed by MEMORIAL SLOAN-KETTERING CANCER CENTER, New York, NY (US)
Filed on Aug. 9, 2019, as Appl. No. 16/536,786.
Application 16/536,786 is a continuation of application No. PCT/US2018/017843, filed on Feb. 12, 2018.
Claims priority of provisional application 62/457,705, filed on Feb. 10, 2017.
Prior Publication US 2020/0003761 A1, Jan. 2, 2020
Int. Cl. C12N 5/074 (2010.01); G01N 33/50 (2006.01); C12N 15/90 (2006.01)

CPC G01N 33/5073 (2013.01) [C12N 5/0607 (2013.01); C12N 15/907 (2013.01); G01N 33/5041 (2013.01); C12N 2310/20 (2017.05)]

9 Claims

1. A method for reprograming cell age, comprising administrating to the cell an epigenetic engineering system, wherein the epigenetic engineering system alters an epigenetic characteristic at a NETO2 gene sequence of the cell.